Abstract
The use is reported of the AngioVac system to resolve a case of persistent bacteremia in the setting of MRSA tricuspid valve infective endocarditis. The infection was secondary to intravenous drug use in a patient who had failed multiple antibiotic regimens and was deemed a poor surgical candidate.
Original language | English |
---|---|
Pages (from-to) | 120-123 |
Number of pages | 4 |
Journal | Journal of Heart Valve Disease |
Volume | 27 |
Issue number | 1 |
State | Published - Jan 1 2018 |
ASJC Scopus subject areas
- General Medicine